Forte Biosciences (FBRX) Prepaid Assets (2016 - 2026)
Forte Biosciences' (FBRX) quarterly Prepaid Assets came in at $6.9 million in Q1 2026, up 428.96% year-on-year from $1.3 million in Q1 2025, and up 89.62% on a QoQ basis from $3.6 million in Q4 2025.
Forte Biosciences (FBRX) Prepaid Assets (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 11 years of Prepaid Assets data on file, last reported at $6.9 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 428.96% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $6.9 million, a 428.96% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 1169.93% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.9 million, up from $3.6 million in the prior quarter.
- Over the last five years, Prepaid Assets for FBRX reached as high as $6.9 million in Q1 2026 and fell as low as $70000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $935235.3 across 5 years, with a median of $286000.0 in 2024.
- Across the five-year window, Prepaid Assets slumped 86.64% in 2022 and jumped 1169.93% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $70000.0 in 2022, then soared by 354.29% to $318000.0 in 2023, then dropped by 10.06% to $286000.0 in 2024, then soared by 1169.93% to $3.6 million in 2025, then surged by 89.62% to $6.9 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $6.9 million in Q1 2026, $3.6 million in Q4 2025, and $471000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Sep 30, 2025 | 471,000.00 |
| Jun 30, 2025 | 213,000.00 |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 286,000.00 |
| Sep 30, 2024 | 274,000.00 |
| Jun 30, 2024 | 214,000.00 |
| Mar 31, 2024 | 233,000.00 |
| Dec 31, 2023 | 318,000.00 |
| Sep 30, 2023 | 917,000.00 |
| Jun 30, 2023 | 322,000.00 |
| Mar 31, 2023 | 260,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 94,000.00 |
| Mar 31, 2022 | 287,000.00 |
| Dec 31, 2021 | 476,000.00 |
| Sep 30, 2021 | 891,000.00 |
| Jun 30, 2021 | 139,000.00 |